Article
Molecular targets of a human HNF1 alpha mutation responsible for pancreatic beta-cell dysfunction.
The EMBO journal - 15 Aug 2000
Wang H, Antinozzi P A, Hagenfeldt K A, Maechler P, Wollheim C B
Abstract excerpt
The reverse tetracycline-dependent transactivator system was employed in insulinoma INS-1 cells to achieve controlled inducible expression of hepatocyte nuclear factor-1 alpha (HNF1 alpha)-P291fsinsC, the most common mutation associated with subtype 3 of maturity-onset diabetes of the young (MODY3). Nuclear localized HNF1 alpha-P291fsinsC protein exerts its dominant-negative effects by competing with endogenous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
